Traditional chinese medicine composition and the use thereof
US-9987324-B2 · Jun 5, 2018 · US
US10646534B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10646534-B2 |
| Application number | US-201715529381-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 20, 2017 |
| Priority date | Dec 15, 2015 |
| Publication date | May 12, 2020 |
| Grant date | May 12, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention belongs to the field of Chinese herbal medicine products, and more particularly relates to a formulation, preparation method and use of a Chinese herbal medicine composition for soothing the liver. The present invention provides a Chinese herbal medicine composition for soothing the liver, wherein the raw materials of the composition comprise Rhizoma Cyperi, Radix Angelicae Sinensis, Rhizoma Ligustici Chuanxiong, Radix Paeoniae Alba , and Pericarpium Citri Reticulatae . The present invention further provides a preparation method of the composition, comprising: step 1, extracting; step 2, concentrating; and Step 3, drying. Moreover, the present invention provides the use of the composition and the product obtained by the method in the treatment of a breast disease and/or remission of depression.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing a Chinese herbal medicine composition for soothing the liver, comprising: Step 1, extracting: adding a first amount of a solvent to a mixture of 20-50 parts by weight of Rhizoma Cyperi, 10-30 parts by weight of Radix Angelicae Sinensis, 10-30 parts by weight of Rhizoma Ligustici Chuanxiong, 5-20 parts by weight of Radix Paeoniae Alba , and 5-20 parts by weight of Pericarpium Citri Reticulatae to perform a first extraction, filtering and collecting a first filtrate; adding a second amount of the solvent to perform a second extraction, filtering and collecting a second filtrate; combining the first filtrate and the second filtrate to obtain an extract; Step 2, concentrating: concentrating the extract under reduced pressure to give a concentrated product; Step 3, drying; and mixing the product obtained after drying with 0.5-10 parts by weight of a green tea extract, wherein the mass ratio of the first amount of the solvent to the mixture is (9-12):1, the extraction time of the first extraction is 1 to 3 hours, and the extraction condition of the first extraction is in boiling; the mass ratio of the second amount of the solvent to the mixture is (7-10):1, the extraction time of the second extraction is 0.5 to 1.5 hours, and the extraction condition of the second extraction is in boiling; the solid content of the concentrated product is 20 to 30%. 2. The method according to claim 1 , further comprising preparing the product obtained after drying into an oral preparation in a dosage form selected from one or more of oral liquid, powder, granule, tablet and capsule. 3. The method according to claim 1 , wherein: the weight of Rhizoma Cyperi is 30 g, the weight of Radix Angelicae Sinensis is 20 g, the weight of Rhizoma Ligustici Chuanxiong is 20 g, the weight of Radix Paeoniae Alba is 10 g, and the weight of Pericarpium Citri Reticulatae is 10 g; the solvent is water, and the first amount of water is 0.9 kg, the second amount of water is 0.72 kg; the extraction time of the first extraction is 1.5 h, and the extraction time of the second extraction is 1 h; the solid content of the concentrated product is 20%; and the weight of the green tea extract is 2 g.
Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying · CPC title
Paeoniaceae (Peony family), e.g. Chinese peony · CPC title
Ligusticum (licorice-root) · CPC title
resulting in pure drug agglomerate optionally containing up to 5% of excipient · CPC title
Extraction of the material · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.